Hitting the BCMA Target in Multiple Myeloma

preview_player
Показать описание
  1. PeerView Oncology
  2. Thomas G. Martin III MD
  3. Krina Patel MD MSc
  4. meded
  5. oncology
  6. hematology
Рекомендации по теме
Hitting the BCMA 0:55:48

Hitting the BCMA Target in Multiple Myeloma

What is BCMA? 0:05:12

What is BCMA? #myeloma

Betting on BCMA 1:20:14

Betting on BCMA Therapy in Multiple Myeloma

Bispecifics, Bispecifics, Bispecifics 0:05:55

Bispecifics, Bispecifics, Bispecifics

Phase 1 Study 0:04:21

Phase 1 Study PHE885 BCMA-Directed CAR-T Cell Therapy for RRMM | Adam Sperling, MD, PhD | ASCO 2023

BCMA: Predicting Outcomes 0:20:03

BCMA: Predicting Outcomes and Monitoring MM and CLL

ASH 2019: New 0:04:19

ASH 2019: New Drugs Targeting BCMA — Immunotherapy for Myeloma | Dr. Gareth Morgan

Innovative Therapy in 1:08:35

Innovative Therapy in Multiple Myeloma: Monoclonal Antibodies and BCMA and Non-BCMA Options

First-in-Human Study of 0:04:28

First-in-Human Study of TNB-383B, a BCMA x CD3 Bispecific T-Cell Redirecting Antibody, in Pts w/RRMM

Tumor-intrinsic resistance to 0:03:37

Tumor-intrinsic resistance to immunotherapies in multiple myeloma

Class comparison of 0:08:04

Class comparison of BCMA-directed therapies in relapsed multiple myeloma

TAEKWONDO vs KARATE 0:00:12

TAEKWONDO vs KARATE | Combinations

Bispecific Antibodies in 0:23:13

Bispecific Antibodies in Multiple Myeloma | Dana-Farber Cancer Institute

What are bispecific 0:02:47

What are bispecific antibodies?

Bispecific Antibodies | 0:06:09

Bispecific Antibodies | High Impact Topic (HIT)

An overview of 0:03:09

An overview of the toxicities associated with immunotherapy in multiple myeloma

Managing toxicities associated 0:01:29

Managing toxicities associated with immunotherapy in multiple myeloma

A New Approach 0:06:52

A New Approach in Using Cells to Target Multiple Myeloma

Therapeutic mAb Discovery 0:29:23

Therapeutic mAb Discovery for Multi-Pass Transmembrane Protein Targets | DIMA Biotech @ CAS 2025

Anti-BCMA CAR T 0:11:27

Anti-BCMA CAR T cell therapy for multiple myeloma

Developments in the 0:07:05

Developments in the use of bispecific antibodies in myeloma and challenges in this space

Clinical Investigator Perspectives: 1:02:04

Clinical Investigator Perspectives: The Most Relevant New Data Sets and Advances in Multiple Myeloma

The evolving treatment 0:01:30

The evolving treatment landscape for multiple myeloma

Dr. Maloney on 0:01:04

Dr. Maloney on Targets for CAR T-Cell Therapy

visit shbcf.ru